Myelodysplastic syndrome of del 20q with plasma cell dysplasia.

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Deletion of the long arm of chromosome 20 (del 20q) has been observed in patients with myelodysplastic syndrome (MDS) or myeloid malignancies. We experienced an MDS female case of del 20q accompanied by clusters of plasmacytic cells in bone marrow. Her bone marrow cells showed morphological abnormalities in three lineages and the chromosomal abnormality of 46, XX, del (20) (q11.2q13.3). Although the percentage of plasma cells was low in free cells, such cells showed nuclear abnormalities. In bone marrow clots, we also observed clusters of anti-CD38 and anti-CD138 antibody-positive cells. According to the FAB or WHO classification, the diagnosis was unclear. Therefore, we were obliged to term this case as MDS with plasma cell dysplasia. This patient was considered to be a rare case of MDS related to abnormalities in myeloid and B-lymphoid cells.

Cite

CITATION STYLE

APA

Saito, N., Higashiura, K., Ehata, K., Kurosawa, S., Honma, K., Abe, M., … Kean Ooi, H. (2011). Myelodysplastic syndrome of del 20q with plasma cell dysplasia. Journal of Clinical and Experimental Hematopathology : JCEH, 51(2), 141–145. https://doi.org/10.3960/jslrt.51.141

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free